- Home
- KOPN vs ASRT Comparison
KOPN vs ASRT Comparison
Compare KOPN & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KOPN | ASRT |
|---|---|---|
| Founded | 1984 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.8M | 76.0M |
| IPO Year | 2025 | 2004 |
Fundamental Metrics
Financial Performance| Metric | KOPN | ASRT |
|---|---|---|
| Price | $4.85 | $23.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | $4.69 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 7.0M | 285.4K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 103.03 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,530,311.00 | ★ $118,713,000.00 |
| Revenue This Year | $50.07 | N/A |
| Revenue Next Year | $33.33 | $12.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 46.53 | N/A |
| 52 Week Low | $1.44 | $0.61 |
| 52 Week High | $6.61 | $23.50 |
Technical Indicators
Market Signals| Indicator | KOPN | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 48.36 | 83.39 |
| Support Level | $4.38 | $11.05 |
| Resistance Level | $6.53 | N/A |
| Average True Range (ATR) | 0.57 | 0.03 |
| MACD | -0.15 | -0.20 |
| Stochastic Oscillator | 18.05 | 100.00 |
Price Performance
Historical ComparisonAbout KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.